Browse > Article
http://dx.doi.org/10.4070/kcj.2011.41.12.754

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation  

Kee, Won-Ju (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Jeong, Myung-Ho (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Jang, Soo-Young (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Lee, Min-Goo (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Park, Keun-Ho (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Sim, Doo-Sun (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Hong, Young-Joon (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Kim, Ju-Han (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Ahn, Young-Keun (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Kang, Jung-Chaee (The Heart Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital)
Publication Information
Korean Circulation Journal / v.41, no.12, 2011 , pp. 754-758 More about this Journal
Abstract
We report our experience of very late stent thrombosis (VLST) in a young male patient who underwent implantation of two paclitaxel-eluting stents (PES) six years ago. The patient was compliant with standard dual antiplatelet therapy, but he presented with acute myocardial infarction which was associated with VLST. Intravascular ultrasound showed neointimal rupture with thrombus within the PES implanted in the right coronary artery. The lesion was successfully treated with balloon angioplasty without complications, however he was found to be hyporesponsive to clopidogrel when tested for adenosine diphosphate-induced platelet aggregation. The patient was discharged after uneventful recovery with triple anti-platelet therapy using aspirin, clopidogrel and cilostazol. To the best of our knowledge, a time interval of 2,223 days is the longest reported time interval between PES deployment and VLST occurrence. VLST may indeed occur in clinically stable patients, as multiple factors can influence the pathological mechanisms of VLST.
Keywords
Coronary thrombosis; Paclitaxel; Ultrasonics; Clopidogrel;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-9.   DOI   ScienceOn
2 Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous cell seeding: remnant endothelium after stenting enhances vascular repair. Circulation 1996;94:2909-14.   DOI   ScienceOn
3 Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007;50:463-70.   DOI   ScienceOn
4 Seol SH, Kim DI, Han YC, et al. Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm. Korean Circ J 2009;39:439-42.   DOI   ScienceOn
5 Kim SS, Jeong MH, Sim DS, et al. Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents. Korean Circ J 2009;39:205-8.   DOI   ScienceOn
6 Ahn YS, Cho JH, Kim DH, et al. A fatal case of simultaneous, very late thrombosis involving three drug-eluting stents in three coronary arteries. Korean Circ J 2008;38:564-9.   DOI   ScienceOn
7 Nam CW, Kim KB, Chung IS. Very late stent thrombosis related to fracture of a sirolimus-eluting stent. Korean Circ J 2007;37:385-7.   DOI   ScienceOn
8 Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9.   DOI   ScienceOn
9 Ellis SG, Colombo A, Grube E, et al. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol 2007;49:1043-51.   DOI   ScienceOn
10 Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008;52:1134-40.   DOI   ScienceOn
11 Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.   DOI   ScienceOn
12 Yokoyama S, Takano M, Sakai S, et al. Difference in neointimal proliferation between ruptured and non-ruptured segments after bare metal stent implantation. Int Heart J 2010;51:7-12.   DOI   ScienceOn
13 Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Identification of low responders to a 300 mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 2005;115:101-8.   DOI
14 Higo T, Ueda Y, Oyabu J, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC Cardiovascular Imaging 2009;2:616-24.   DOI
15 Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.   DOI   ScienceOn
16 Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-7.